| 1809249-37-3 Basic information More.. |
Product Name: | Remdesivir | Synonyms: | Remdesivir;Remdesivir API;Remdesivir Powder;high purity Remdesivir;Redecivir (API);Remdesivir liquid;Remdesivir lypholized powder;remdesivir producing | CAS: | 1809249-37-3 | MF: | C27H35N6O8P | MW: | 602.58 | EINECS: | 210-629-4 | Mol File: | 1809249-37-3.mol | |
Use
Remdesivir is an antiviral nucleotide analogue used for therapy of severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection. Remdesivir therapy is given intravenously for 3 to 10 days and is frequently accompanied by transient, reversible mild-to-moderate elevations in serum aminotransferase levels but has been only rarely linked to instances of clinically apparent liver injury, its hepatic effects being overshadowed by the systemic effects of COVID-19.
- Remdesivir
-
- US $0.00-0.00 / kg
- 2024-09-28
- CAS:1809249-37-3
- Min. Order: 1kg
- Purity: 99.0%min. HPLC
- Supply Ability: 1000kg
- Remdesivir
-
- US $8.70 / kg
- 2024-09-26
- CAS:1809249-37-3
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 10000kg
- REMDESIVIR
-
- US $20.00 / kg
- 2024-09-23
- CAS:1809249-37-3
- Min. Order: 1kg
- Purity: 99
- Supply Ability: 1000kg
|
1809249-37-3
Recommend Suppliers |
|